WHAT IS SHINGLES?

Shingles is a disease caused by the varicella-zoster virus, the same virus that causes chickenpox. After an attack of chickenpox, the virus lies dormant in the nerve tissue. As we get older, it is possible for the virus to reappear in the form of shingles. Shingles is estimated to affect 2 in every 10 people in their lifetime. This year, more than 500,000 people will develop shingles. Fortunately, scientists are doing research to find a vaccine to prevent the disease.

WHO IS AT RISK FOR DEVELOPING SHINGLES?

Although it is most common in people over age 50, if you have had chickenpox, you are at risk for developing shingles. Shingles is also more common in people with weakened immune systems from HIV infection, chemotherapy or radiation treatment, transplant operations, and stress.

WHAT ARE THE SYMPTOMS OF SHINGLES?

Early signs of shingles include burning or shooting pain and tingling or itching generally located on one side of the body or face. The pain can be severe. Rash or blisters are present anywhere from 1 to 14 days.

ARE OTHER COMPLICATIONS ASSOCIATED WITH SHINGLES?

Yes. If shingles appears on your face, it can lead to complications in your hearing and vision. For instance, if shingles affects your eye, the cornea can become infected and lead to temporary or permanent blindness. Another complication of the virus is postherpetic neuralgia (PHN), a condition where the pain from shingles persists for months, sometimes years, after the shingles rash has healed.

IS THERE A CURE OR TREATMENT FOR SHINGLES?

There is no cure for shingles, but the severity and duration of an attack of shingles can be significantly reduced if you are treated immediately with antiviral drugs, which include acyclovir, valacyclovir, or famcyclovir. Antiviral drugs may also help stave off the painful
after-effects of PHN. Other treatments for PHN include painkillers, steroids, antidepressants, and antiseizure medicine.

The National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, and other institutes of the National Institutes of Health (NIH) conduct shingles research in NIH laboratories and support additional research through grants to major medical institutions across the country. Current research is aimed at finding new methods for treating shingles and its complications.

IS THERE A VACCINE TO PREVENT SHINGLES?

In May 2006, the Food and Drug Administration approved use of a vaccine to prevent shingles. The vaccine, called Zostavax, is recommended for people 60 years of age and older who have had chickenpox but who have not had shingles. Researchers estimate the vaccine could prevent 250,000 cases of shingles that occur in the United States each year and significantly reduce the severity of the disease in another 250,000 cases annually.

MORE INFORMATION

National Library of Medicine
MedlinePlus
8600 Rockville Pike
Bethesda, MD 20894
1-888-FIND-NLM (1-888-346-3656) or 301-594-5983
http://medlineplus.gov

National Institute on Aging Information Center
P.O. Box 8057
Gaithersburg, MD 20898-8057
1-800-222-2225
http://www.nia.nih.gov

National Institute of Neurologic Disorders and Stroke
P.O. Box 5801
Bethesda, MD 20824
1-800-352-9424 or 301-496-5751
http://www.ninds.nih.gov

National Institutes of Health
http://nihseniorhealth.gov